Amresco Revenue and Competitors

Solon, OH USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Amresco's estimated annual revenue is currently $18.3M per year.(i)
  • Amresco's estimated revenue per employee is $155,000

Employee Data

  • Amresco has 118 Employees.(i)
  • Amresco grew their employee count by -2% last year.

Amresco's People

NameTitleEmail/Phone
1
SVP ComplianceReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
Senior Production ManagerReveal Email/Phone
4
Quality Control Sr. ManagerReveal Email/Phone
5
Sr. Project ManagerReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
Master PlannerReveal Email/Phone
8
Bulk Sales RepresentativeReveal Email/Phone
9
QC MicrobiologyReveal Email/Phone
10
Inventory Analyst/LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is Amresco?

Business Services

keywords:N/A

N/A

Total Funding

118

Number of Employees

$18.3M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Amresco News

2022-04-19 - Glycylglycine Gly-Gly Market Latest Research Report| VWR ...

Glycylglycine Gly-Gly Market Latest Research Report| VWR AMRESCO, Bio Basic Inc., PhytoTech Labs. Photo of Nikolai NikolaiApril 20, 2022. 0 3 minutes read.

2022-04-17 - Global G418 Market Trends, Status and Future Forecast 2022-2027 ...

Amresco, InvivoGen, Thermo Fisher Scientific, Merck, Yancheng YouHua Pharmaceutical & Chemical. The archive further offers significant data...

2022-04-17 - Ammonium Phosphomolybdate Market Size 2022 Analysis By Top ...

ThermoFisher; Amresco; Acros; Alfa Aesar; Spectrum; Klamar; Sinopharm Group; Sigma-Aldrich; TCI. Ammonium Phosphomolybdate Market Breakdown by...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.3M12134%N/A
#2
$30.6M122-3%N/A
#3
$21.7M1242%N/A
#4
$75M132N/AN/A
#5
$15M1374%N/A